Effect of Coffee Consumption on the Glycemic Index of Khalas Dates Tested in Healthy and Diabetic Subjects
NCT ID: NCT01422668
Last Updated: 2011-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
23 participants
INTERVENTIONAL
2010-03-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing the Glycaemic Index of Two Different Cultivars of Date Fruit
NCT03769389
Association Between Dietary Pattern and Glycemic Control Among Type 2 Diabetes Patients in the Unites Arab Emirates
NCT03388229
Experimental Studies of the Effects of Caffeine on Glucose Regulation
NCT00432887
Date Fruit Effects in Type 2 Diabetes
NCT04616066
The Effect of Biscuit Containing Kothala Himbutu on Blood Glucose in Patients With Diabetes. A Randomized Control Study
NCT02290925
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods:Composition analysis was carried out for Khalas dates (Tamer stage) and the weight of the dates flesh equivalent to 50 g of available carbohydrate was calculated. The study subjects were thirteen healthy volunteers with a mean (± SD) age of 40.2 ± 6.7 years and ten participants with type 2 diabetes mellitus (controlled on lifestyle measures and/or metformin) with a mean HbA1c (± SD) of 6.6 ± (0.7 %) and a mean age (± SD) of 40.8 ± 5.7 years. Each subject was tested on five separate days with 50 g of glucose (on 3 occasions) and 50 g equivalent of available carbohydrates from the dates without coffee (on one occasion) and with coffee (on another occasion). Capillary glucose was measured in the healthy subjects at 0, 15, 30, 45, 60, 90 and 120 min and for the diabetics at 0, 30, 60, 90, 120, 150 and 180 min. The glycemic indices were determined as ratios of the incremental areas under the response curves for the dates alone/with coffee compared to glucose. Statistical analyses were performed using Student's t-tests.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GI of Khalas dates
The Glycemic indices of the Khalas dates were measured for healthy and diabetic subjects.
Khalas dates
every subject recieved 50 grams reducing carbohydrates equivalent of khalas dates
GI of the Khalas dates with Coffee
measuring the effect of 100 ml of coffee consumption on the GI of the Khalas dates among healthy and diabetic subjects.
Khalas dates
every subject recieved 50 grams reducing carbohydrates equivalent of khalas dates
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Khalas dates
every subject recieved 50 grams reducing carbohydrates equivalent of khalas dates
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pre diabetes
* pregnancy
* presence of gastroenterological disorders
* alimentary tract surgery
* a history of gastroenteritis in the prior six months
* any alcohol intake
* smoking
* taking any medications (except metformin)
* poorly controlled diabetes (HbA1c \> 8%) and the presence of acute or chronic diseases
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United Arab Emirates University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Juma Alkaabi
Assistant Professor of Medicine, Faculty of Medicine and Health Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juma M Alkaabi, MD
Role: PRINCIPAL_INVESTIGATOR
Assistant professor Internal Medicine Department FMHS UAE University
Bayan Al-Dabbag, PhD
Role: STUDY_CHAIR
FMHS UAE university
Hussein Saadi, MD
Role: STUDY_CHAIR
Professor of Medicine, FMHS UAE University
Salah Gariballa, MD
Role: STUDY_CHAIR
Professor of Medicine FMHS UAE University
Yasin Javed, Msc
Role: STUDY_CHAIR
FMHS UAE University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine and Health Sciences UAE University
Al Ain City, AB, United Arab Emirates
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UAEU: GI Dates Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.